Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetesJūlı́us Guðmundsson, Theresa Graif, Guðmar Þorleifsson et al.|Nature Genetics|2007Cited by 725
Recommendation for validation and quality assurance of non‐invasive prenatal testing for foetal blood groups and implications for <scp>IVD</scp> risk classification according to <scp>EU</scp> regulationsFrederik Banch Clausen, Tobias J. Legler, Åsa Hellberg et al.|Vox Sanguinis|2021Cited by 21